<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To identify cell proteins regulated by the Epstein-Barr virus (EBV) transcription factor EBNA-2, we analyzed a cell line with conditional EBNA-2 activity by using microarray expression profiling </plain></SENT>
<SENT sid="1" pm="."><plain>This led to the identification of two novel target genes induced by EBNA-2 </plain></SENT>
<SENT sid="2" pm="."><plain>The first of these, interleukin-16, is an immunomodulatory cytokine involved in the regulation of CD4 T cells </plain></SENT>
<SENT sid="3" pm="."><plain>The second, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-2, is a member of the <z:mp ids='MP_0001265'>Runt</z:mp> domain family of transcription factors </plain></SENT>
<SENT sid="4" pm="."><plain>Quiescent B cells initially expressed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-1 but, 48 h after <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e>, the levels of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-1 decreased dramatically, whereas the amount of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-2 protein increased </plain></SENT>
<SENT sid="5" pm="."><plain>Analysis of a panel of B-cell lines indicated that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-2 expression is normally predominant in EBV latency III, whereas <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-1 is associated with EBV latency I or EBV-negative cells </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> genes are the first example of cell transcription factors whose expression correlates with the latency I/III phenotype </plain></SENT>
</text></document>